On February 9, 2021, Tang Capital Partners, LP, Tang Capital Management, LLC announced that it has seeking to: (i) nominate, and hereby nominates, each of Kevin Tang and Thomas Wei as directors for election at the 2021 annual meeting of stockholders of Aptevo Therapeutics Inc., and at any other meeting of stockholders held in lieu thereof, and at any adjournments, postponements, rescheduling or continuations thereof; and (ii) put forward the advisory proposal to acquire the outstanding stock of the Company for $50 per share at the annual meeting.